Case Reports in Endocrinology

Case Reports in Endocrinology / 2012 / Article

Case Report | Open Access

Volume 2012 |Article ID 580481 |

Masanori Murakami, Noriko Matsushita, Rie Arai, Naohiro Takahashi, Ryuki Kawamura, Sayaka Suzuki, Sachio Takekawa, Fumiko Iwashima, Takashi Shibui, Akihiro Hata, Yoshihiro Ogawa, Toshiyuki Horiuchi, "Isolated Adrenocorticotropin Deficiency Associated with Delirium and Takotsubo Cardiomyopathy", Case Reports in Endocrinology, vol. 2012, Article ID 580481, 5 pages, 2012.

Isolated Adrenocorticotropin Deficiency Associated with Delirium and Takotsubo Cardiomyopathy

Academic Editor: T. Kita
Received12 Oct 2012
Accepted05 Nov 2012
Published03 Dec 2012


We report a 65-year-old woman with isolated adrenocorticotropic hormone (ACTH) deficiency. The patient was transported to the emergency outpatient department by ambulance complaining of malaise and nausea. Because her laboratory data revealed hyponatremia, we performed endocrinological examinations and diagnosed isolated ACTH deficiency. After admission, she went into a delirious state and suffered from takotsubo cardiomyopathy due to adrenal insufficiency. Replacement therapy with hydrocortisone sufficiently improved her delirium and cardiomyopathy. We conclude that her unstable mental state and myocardial dysfunction were closely related to adrenal insufficiency and suggest that adrenal crisis may cause delirium and Takotsubo cardiomyopathy.

1. Introduction

Isolated adrenocorticotropic hormone (ACTH) deficiency causes secondary hypocortisolism. Major symptoms, which include general malaise, fatigability, anorexia, hypotension, and disturbance of consciousness, are due to hypoglycemia or hyponatremia. Isolated ACTH deficiency is suspected when hypocortisolism is present in addition to the major symptoms already listed. A definite diagnosis requires low or absent serum ACTH or cortisol levels under corticotropin-releasing hormone (CRH) challenge. Although depression-like symptoms are common in hypocortisolism [1], only three cases of delirium with isolated ACTH deficiency have been reported [24]. In addition, there were some reports of ACTH deficiency associated with Takotsubo cardiomyopathy [59], which is characterized by transient left ventricular apical wall motion abnormality with electrocardiographic changes and minimal myocardial enzymatic release mimicking acute myocardial infarction, but without significant coronary artery disease [1015].

Here, we report a case of delirium and Takotsubo cardiomyopathy during acute adrenal crisis due to isolated ACTH deficiency.

2. Case Report

A 65-year-old woman was admitted to our hospital, complaining of malaise and nausea of one-week duration without preceding infection. She had been in good health until that time except for suffering from Hashimoto’s disease, which was treated with thyroid hormone, levothyroxine 75 μg/day in another hospital and was well controlled. She was nulligravida and menopausal at 60 years old. In addition, she had no psychiatric history.

On admission, her body temperature was 35.6°C, blood pressure 157/94 mmHg, and pulse rate 75/min. She exhibited obtundation and her Glasgow Coma Scale was 14 (E4V4M6). Physical examination showed no abnormalities. Her skin and mucosa were free of unusual pigmentation and there were no lack of physiological pigmentation and body hair. Laboratory findings showed only low serum levels of sodium (116 mEq/L, Table 1). On electrocardiogram (ECG), T waves were inverted in leads II, III, V1, and V2 as minor abnormalities (Figure 1).

Peripheral blood
 White blood cells4600/ L (3300–9500)
  Neutrophils68.5% (37–80)
  Lymphocytes19.7% (11–50)
  Monocytes10.3% (4–11)
  Basophils0.2% (0–2)
  Eosinophils1.3% (0–8)
 Red blood cells386 × 104/ L (389–501)
 Hemoglobin11.7 g/dL (11.3–15.2)
 Hematocrit30.2% (33.4–46.4)
 Platelet16.2 × 104/ L (14–36)

Serum chemistry
 Sodium116 mEq/L (136–147)
 Potassium4.5 mEq/L (3.5–5.0)
 Chloride84 mEq/L (95–110)
 Glucose132 mg/dL (70–110)
 Urea nitrogen6.4 mg/dL (7.0–22.0)
 Creatinine0.52 mg/dL (0.40–0.90)
 Uric acid3.1 mg/dL (0.0–7.0)
 Total protein6.1 g/dL (6.3–8.5)
 Albumin3.8 g/dL (3.3–5.1)
 Aspartate aminotransferase 33 IU/L (10–38)
 Alanine aminotransferase 15 IU/L (6–38)
 Lactate dehydrogenase 211 IU/L (115–255)
 C-reactive protein0.3 mg/dL (0.0–0.2)

Figures in parentheses indicate the normal range.

After admission, her consciousness levels were improved for alertness and we tried to treat the hyponatremia by intravenous infusion. However, four days after admission, she presented with paranoia and visual hallucinations. She said, for example, “I was arrested in the hospital,” “The pattern on the walls began to spin,” and “Grass is growing on the window panes.” She was delirious. We consulted psychiatrists who prescribed quetiapine for her delirium. Furthermore, on the same day, she complained of nausea and was pale and sweating. Her blood pressure was 63/48 mmHg, body temperature was 36.0°C, and her SpO2 index was unstable (70–90%). She was thought to be in a state of acute circulatory failure. Because the electrocardiogram showed new inverted T waves in leads V2-5 (Figure 1), urgent coronary catherization was performed for possible percutaneous intervention. However, coronary angiography demonstrated no significant coronary stenosis. Left ventriculography showed akinesis of the left ventricular apex with ballooning during systole (Figure 2). Blood examination revealed neither significant hypoglycemia nor electrolyte abnormalities other than hyponatremia (118 mEq/L). The serum levels of creatinine kinase (CK) (603 IU/L), CK-MB (24 IU/L), and troponin I (6.80 ng/mL) were slightly elevated. These findings are consistent with Takotsubo cardiomyopathy.

Considering her status of hyponatremia, delirium, and Takotsubo cardiomyopathy, we supposed she could be suffering an acute adrenal crisis and started intravenous administration of 400 mg/day hydrocortisone. On the following day, we confirmed decreased cortisol (2.2 μg/dL, Table 2(a)) and ACTH (8.4 pg/mL) levels and began oral administration of 20 mg/day hydrocortisone. Following the administration of hydrocortisone, the hyponatremia and delirium improved dramatically in 3 days. Her sodium level reached 139 mEq/L and her consciousness level became alert. An echocardiogram showed the left ventricular wall motion abnormalities including apical segment to be also markedly improved by 10 days after steroid administration.

(a) Basal levels

ACTH8.4 pg/mL (7.2–63.3)
Cortisol2.2 μg/dL (4.0–18.3)
TSH1.52 μIU/mL (0.55–4.78)
FT32.38 pg/mL (2.13–4.07)
FT41.89 ng/dL (0.89–1.76)
Plasma renin activity0.3 ng/mL/hr (0.3–2.9)
Plasma aldosterone76.8 pg/mL (29.9–159.0)
Urine free cortisol8.7 μg/day (11.2–80.3)
Urine metanephrine0.03 mg/day (0.04–0.19)
Urine normetanephrine0.16 mg/day (0.09–0.33)

Figures in parentheses indicate the normal range.
(b) Rapid ACTH test

Time (min)03060

Cortisol ( g/dL)5.414.116.8

(c) CRH, LHRH, GRH test

Time (min)0306090120

ACTH (pg/mL)7.814.311.79.28.3
Cortisol ( g/dL)
LH (mIU/mL)19.9264.3168.0466.762.75
FSH (mIU/mL)64.5075.3779.8682.4486.36
GH (ng/mL)0.648.7212.312.14.66

(d) Continuous ACTH test


Urine free cortisol (μg/day)

Endocrine studies showed decreases in serum cortisol and ACTH and reduced urinary secretion of free cortisol. The plasma cortisol level responded slightly after a bolus injection of 0.25 mg ACTH (Table 2(b)). In addition, continuous ACTH-Z stimulation (0.5 mg injected daily for 4 days) produced a gradual but clear increase in the urinary excretion of free cortisol (Table 2(d)). Treatment with ACTH-releasing hormone did not increase the plasma ACTH concentration (Table 2(c)). On the other hand, growth hormone (GH) levels were increased by GH-releasing hormone (Table 2(c)). Although the luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels were slightly increased by LH-releasing hormone, their basal levels were high enough because of her postmenopausal state, and we consider that LH- and FSH-releasing ability was unimpaired (Table 2(c)). We did not perform an infusing TSH-releasing hormone test. Because she was under treatment for Hashimoto’s disease involving levothyroxine intake and euthyroid upon admission (Table 2(a)), her hypothalamus function with respect to TSH-releasing ability should not have been impaired. We also did not perform an insulin tolerance test (ITT) because she was elderly and the possibility of severe cardiac involvement was present. Plasma renin activity and plasma aldosterone concentration were normal (Table 2(a)). Therefore, the diagnosis of isolated ACTH deficiency was made. Magnetic resonance imaging (MRI) revealed no pituitary lesions or adjacent lesions.

3. Discussion

Adrenal insufficiency was conclusively diagnosed following endocrinological examination based on the markedly decreased plasma cortisol level. The ACTH level was low while the remaining pituitary functions were normal, which led to the diagnosis of isolated ACTH deficiency. Although our patient complained of malaise and nausea for a week prior to admission, the plasma cortisol level responded slightly (<18 μg/mL) after a bolus injection of 0.25 mg ACTH (Table 2(b)). It was considered that she had suffered secondary insufficiency for more than a week.

Three cases of delirium concurrent with isolated ACTH deficiency have been reported [24] (Table 3). Administration of hydrocortisone dramatically improved consciousness in all cases including ours, and this immediate improvement suggests significant links between delirium and adrenal insufficiency. Interestingly, the patient in our case showed paranoid thinking and visual hallucinations. In the previous reports, the patients showed symptoms that included incoherent speech, disorientation, and incontinence [24]. We believe our case is the first to describe delirium concurrent with isolated ACTH deficiency, presenting paranoid thinking and visual hallucinations. Considering all reports [24] (Table 3), most cases developed delirium with preceding unresolved gastrointestinal symptoms in accordance with hyponatremia in geriatric patients. In addition, they did not have any special psychiatric history. Facing delirium patients having these situations, clinicians should pay attention to adrenal insufficiency as a cause of delirium.

CaseAge/SexPast historyPreceding duration of physical symptomsMental symptomsNormalization of deliriumSteroid hormone therapyReference

168/MStroke4 monthsDisorientation to time and place
1 dayCortisone acetate
25 mg/d PO for 10 days
37.5 mg/d PO
274/M1 weekDelirious state3 daysHydrocortisone
Details unclear
367/MCholecystitis7 weeksIncoherent speech and conduct
Details unclearHydrocortisone
20 mg/d PO
465/FHashimoto’s disease1 weekParanoia
visual hallucinations
3 daysHydrocortisone
400 mg/d IV for 2 days
20 mg/d PO
Present case

PO: per os, IV: intravenously, and d: day.

Takotsubo cardiomyopathy is now an established syndrome worldwide [1619], but there are no universally accepted diagnostic criteria for this syndrome. Major clinical characteristics are as follows. First, the symptoms are similar to those of acute myocardial infarction. Second, most cases involve elderly woman. Third, Takotsubo-like left ventricular dysfunction, which extends over more than one coronary artery region, is transient and resolves within several weeks. These findings are consistent with our case. Furthermore, myocardial damage is usually excluded when the CK-MB is <5 or 6% of the total CK activity; in our case, the CK-MB was 4.1% of the total CK activity. The CK elevation may result not from myocardial damage, but rather from the skeletal muscle. Pheochromocytoma can cause myocardial damage unrelated to the coronary arteries [20]. Therefore, although we measured the plasma and urine catecholamine levels, they were within normal limits (Table 2(a)). In addition, computed tomography of the abdomen did not indicate the presence of a mass lesion, which suggests pheochromocytoma; therefore, we ruled out pheochromocytoma.

In our case, immediate replacement therapy with hydrocortisone sufficiently improved her cardiomyopathy. Therefore, we could conclude that her myocardial dysfunction was closely related to adrenal insufficiency. Six cases of reversible left ventricular dysfunction or cardiomyopathy associated with isolated ACTH deficiency have been reported previously [59]. Similar to these six cases, intensive stress induced by adrenal insufficiency caused reversible cardiomyopathy in our patient, although the detailed mechanism of left ventricular dysfunction in Takotsubo cardiomyopathy remains unknown [1017]. According to the report by Ukita et al. [8], they listed all cases of Takotsubo cardiomyopathy with isolated ACTH deficiency [57]. Comparing those cases, we found that all cases including ours were female patients although we could not figure out the meanings of the sex difference. Furthermore, though patients with Takotsubo cardiomyopathy often feel chest pain, most of cases with isolated ACTH deficiency did not feel chest pain including ours. Interestingly, Gotyo et al. reported male patient developing Takotsubo cardiomyopathy with idiopathic ACTH deficiency [9]. Their patient also impaired GH secretion, and it was not isolated ACTH deficiency with regard to definition; therefore, they used the word idiopathic ACTH deficiency.

To our knowledge, this case represents the first report of both delirium and Takotsubo cardiomyopathy associated with isolated ACTH deficiency. In summary, the present case of a patient suffering from delirium and Takotsubo cardiomyopathy was subsequently diagnosed with adrenal insufficiency induced by isolated ACTH deficiency secondary to a diagnosis of hyponatremia. Both symptoms resolved immediately after the start of steroid replacement therapy with no subsequent relapse; therefore, the unstable mental status and cardiac dysfunction are considered to have been secondary to adrenal insufficiency. Therefore, patients with delirium or Takotsubo cardiomyopathy with no apparent etiology should be examined for adrenal function and begin immediate steroid replacement, if needed.


  1. W. Arlt and B. Allolio, “Adrenal insufficiency,” The Lancet, vol. 361, no. 9372, pp. 1881–1893, 2003. View at: Publisher Site | Google Scholar
  2. V. S. Fang and J. B. Jaspan, “Delirium and neuromuscular symptoms in an elderly man with isolated corticotroph-deficiency syndrome completely reversed with glucocorticoid replacement,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 5, pp. 1073–1077, 1989. View at: Google Scholar
  3. K. Nemoto, Y. Kawanishi, H. Suzuki, K. Mizukami, and T. Asada, “Isolated adrenocorticotropic hormone deficiency presenting with delirium,” American Journal of Psychiatry, vol. 164, no. 9, p. 1440, 2007. View at: Publisher Site | Google Scholar
  4. H. Imai, K. Matsuishi, N. Kitamura et al., “Isolated adrenocorticotropic hormone deficiency accompanied with delirium,” Psychiatry and Clinical Neurosciences, vol. 63, no. 3, pp. 426–427, 2009. View at: Publisher Site | Google Scholar
  5. K. Iga, K. Hori, and H. Gen, “Deep negative T waves associated with reversible left ventricular dysfunction in acute adrenal crisis,” Heart and Vessels, vol. 7, no. 2, pp. 107–111, 1992. View at: Publisher Site | Google Scholar
  6. K. Eto, T. Koga, A. Sakamoto, N. Kawazoe, S. Sadoshima, and K. Onoyama, “Adult reversible cardiomyopathy with pituitary adrenal insufficiency caused by empty sella—a case report,” Angiology, vol. 51, no. 4, pp. 319–323, 2000. View at: Google Scholar
  7. S. Sakihara, K. Kageyama, T. Nigawara, Y. Kidani, and T. Suda, “Ampulla (takotsubo) cardiomyopathy caused by secondary adrenal insufficiency in ACTH isolated deficiency,” Endocrine Journal, vol. 54, no. 4, pp. 631–636, 2007. View at: Publisher Site | Google Scholar
  8. C. Ukita, H. Miyazaki, N. Toyoda, A. Kosaki, M. Nishikawa, and T. Iwasaka, “Takotsubo cardiomyopathy during acute adrenal crisis due to isolated adrenocorticotropin deficiency,” Internal Medicine, vol. 48, no. 5, pp. 347–352, 2009. View at: Publisher Site | Google Scholar
  9. N. Gotyo, M. Kida, T. Horiuchi, and Y. Hirata, “Torsade de pointes associated with recurrent ampulla cardiomyopathy in a patient with idiopathic ACTH deficiency,” Endocrine Journal, vol. 56, no. 6, pp. 807–815, 2009. View at: Publisher Site | Google Scholar
  10. K. Dote, H. Sato, H. Tateishi, T. Uchida, and M. Ishihara, “Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases,” Journal of Cardiology, vol. 21, no. 2, pp. 203–214, 1991. View at: Google Scholar
  11. S. Kawai, H. Suzuki, H. Yamaguchi et al., “Ampulla cardiomyopathy (“Takotusbo” cardiomyopathy) reversible left ventricular dysfunction with ST segment elevation,” Japanese Circulation Journal, vol. 64, no. 3, pp. 156–159, 2000. View at: Google Scholar
  12. K. Tsuchihashi, K. Ueshima, T. Uchida et al., “Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan,” Journal of the American College of Cardiology, vol. 38, no. 1, pp. 11–18, 2001. View at: Publisher Site | Google Scholar
  13. Y. J. Akashi, K. Nakazawa, M. Sakakibara, F. Miyake, H. Koike, and K. Sasaka, “The clinical features of takotsubo cardiomyopathy,” QJM, vol. 96, no. 8, pp. 563–573, 2003. View at: Publisher Site | Google Scholar
  14. S. Kurisu, H. Sato, T. Kawagoe et al., “Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction,” American Heart Journal, vol. 143, no. 3, pp. 448–455, 2002. View at: Publisher Site | Google Scholar
  15. Y. Abe, M. Kondo, R. Matsuoka, M. Araki, K. Dohyama, and H. Tanio, “Assessment of clinical features in transient left ventricular apical ballooning,” Journal of the American College of Cardiology, vol. 41, no. 5, pp. 737–742, 2003. View at: Publisher Site | Google Scholar
  16. K. A. Bybee, T. Kara, A. Prasad et al., “Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction,” Annals of Internal Medicine, vol. 141, no. 11, pp. 858–865, 2004. View at: Google Scholar
  17. S. W. Sharkey, W. Shear, M. Hodges, and C. A. Herzog, “Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness,” Chest, vol. 114, no. 1, pp. 98–105, 1998. View at: Google Scholar
  18. P. S. Seth, G. P. Aurigemma, J. M. Krasnow, D. A. Tighe, W. J. Untereker, and T. E. Meyer, “A syndrome of transient left ventricular apical wall motion abnormality in the absence of coronary disease: a perspective from the United States,” Cardiology, vol. 100, no. 2, pp. 61–66, 2003. View at: Publisher Site | Google Scholar
  19. W. J. R. Desmet, B. F. M. Adriaenssens, and J. A. Y. Dens, “Apical ballooning of the left ventricle: first series in white patients,” Heart, vol. 89, no. 9, pp. 1027–1031, 2003. View at: Google Scholar
  20. K. Iga, H. Gen, G. Tomonaga, T. Matsumura, and K. Hori, “Reversible left ventricular wall motion impairment caused by pheochromocytoma. A case report,” Japanese Circulation Journal, vol. 53, no. 7, pp. 813–818, 1989. View at: Google Scholar

Copyright © 2012 Masanori Murakami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1892 Views | 632 Downloads | 4 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.